Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
David Conti et al.
NATURE GENETICS (2021)
Immune Inflammation Pathways as Therapeutic Targets to Reduce Lethal Prostate Cancer in African American Men
Maeve Kiely et al.
CANCERS (2021)
Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment
Ebonee N. Butler et al.
BRITISH JOURNAL OF CANCER (2020)
Prostate carcinogenesis: inflammatory storms
Johann S. de Bono et al.
NATURE REVIEWS CANCER (2020)
Cancer statistics for African Americans, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
The IFN-λ4 Conundrum: When a Good Interferon Goes Bad
Olusegun O. Onabajo et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Genetic Hitchhiking and Population Bottlenecks Contribute to Prostate Cancer Disparities in Men of African Descent
Joseph Lachance et al.
CANCER RESEARCH (2018)
IFNL4-ΔG is associated with prostate cancer among men at increased risk of sexually transmitted infections
Tsion Zewdu Minas et al.
COMMUNICATIONS BIOLOGY (2018)
IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling
Adeola A. Obajemu et al.
JOURNAL OF IMMUNOLOGY (2017)
Aspirin Use Reduces the Risk of Aggressive Prostate Cancer and Disease Recurrence in African-American Men
Cheryl Jacobs Smith et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Genetic Ancestry and Natural Selection Drive Population Differences in Immune Responses to Pathogens
Yohann Nedelec et al.
CELL (2016)
Human Herpesvirus 8 Establishes a Latent Infection in Prostates of Tobago Men Resulting in Increased Macrophage Infiltration
Jill D. Henning et al.
PROSTATE (2016)
Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
Siobhan Sutcliffe et al.
CANCER CAUSES & CONTROL (2015)
Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation
Oriol Manuel et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Detection of infectious organisms in archival prostate cancer tissues
Melissa A. Yow et al.
BMC CANCER (2014)
Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
Bora Gurel et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Ewa Terczynska-Dyla et al.
NATURE COMMUNICATIONS (2014)
Cancer incidence in South Asian migrants to England, 1986-2004: Unraveling ethnic from socioeconomic differentials
Camille Maringe et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson et al.
NATURE GENETICS (2013)
Thirty years of research on infection and prostate cancer: No conclusive evidence for a link. A systematic review
Jan Hrbacek et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Intratumoral inflammation is associated with more aggressive prostate cancer
Joseph C. Klink et al.
WORLD JOURNAL OF UROLOGY (2013)
Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study
Jan Hrbacek et al.
BMC CANCER (2011)
Detection of HHV-8 (human herpesvirus-8) genomes in induced peripheral blood mononuclear cells (PBMCs) from US blood donors
L. Qu et al.
VOX SANGUINIS (2011)
Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies
Alison L. Van Dyke et al.
CYTOKINE (2009)
Sexually transmissible infections and prostate cancer risk
Wen-Yi Huang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Tumor immunobiological differences in prostate cancer between African-American and European-American men
Tiffany A. Wallace et al.
CANCER RESEARCH (2008)
Cumulative association of five genetic variants with prostate cancer
S. Lilly Zheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Risk factors for prostate cancer incidence and progression in the health professionals follow-up study
Edward Giovannucci et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects
F. J. Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
No link between viral findings in the prostate and subsequent cancer development
J. Bergh et al.
BRITISH JOURNAL OF CANCER (2007)
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
Matthew L. Freedman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Detection of human Herpesvirus 8 (HHV-8) in normal prostates
J. D. Montgomery et al.
PROSTATE (2006)
A common variant associated with prostate cancer in European and African populations
Laufey T. Amundadottir et al.
NATURE GENETICS (2006)
Prostate cancer epidemiology
AW Hsing et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer
LJ Hoffman et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors
PE Pellett et al.
TRANSFUSION (2003)
Reactivation of and primary infection with human herpesvirus 8 among solid-organ transplant recipients
FJ Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Sexual behaviour, STDs and risks for prostate cancer
RB Hayes et al.
BRITISH JOURNAL OF CANCER (2000)